Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumason CEUS for Hypoxic Ischemic Injury in Neonates
NCT03549520Phase 3Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Dec 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfur hexafluoride in hypoxic-ischemic encephalopathy (HIE), sponsored by Children's Hospital of Philadelphia. Started Dec 2020; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT03549520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549520.